Not available
Quote | Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX)
Last: | $15.12 |
---|---|
Change Percent: | -0.48% |
Open: | $14.8 |
Close: | $15.12 |
High: | $15.185 |
Low: | $14.73 |
Volume: | 941,410 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX)
2024-04-23 10:29:06 ET More on Edgewise Therapeutics Edgewise Therapeutics: Behind The Massive Rally Krystal Biotech, Candel, Edgewise gain after FDA fast track tags Seeking Alpha’s Quant Rating on Edgewise Therapeutics Historical earnings data for Edg...
CORAL GABLES, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients livin...
Message Board Posts | Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CPRX News Article - Catalyst Pharmaceuticals Announces Release of Inaugural ESG Report | whytestocks | investorshangout | 05/01/2023 4:35:51 PM |
whytestocks: $CPRX News Article - Catalyst Pharmaceuticals Named BioFlorida 2022 Company of the Year | whytestocks | investorshangout | 11/07/2022 3:40:51 PM |
whytestocks: $CPRX News Article - These 3 Stocks Are Winning the Bear Market -- Here's How | whytestocks | investorshangout | 10/21/2022 3:30:49 PM |
AviseAnalytics: CATALYST PHARMACEUTICALS: NEXT BIG THING ON S&P SMALLCAP 600 $CPRX Excited to sh | AviseAnalytics | investorshangout | 09/14/2022 12:33:24 PM |
znewcar1: CPRX 23% v4,1M c13.13 f102,8M H13.24ML7.36 | znewcar1 | investorshangout | 08/10/2022 9:49:28 PM |
News, Short Squeeze, Breakout and More Instantly...
Catalyst Pharmaceuticals Inc. Company Name:
CPRX Stock Symbol:
NASDAQ Market:
Catalyst Pharmaceuticals Inc. Website:
CORAL GABLES, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients livin...
CORAL GABLES, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ:CPRX), a commercial-stage, pa...
CORAL GABLES, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and ...